Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
NPJ Cardiovascular Health|July 10, 2026
Semaglutide cardiovascular outcomes align more closely with attained dose than achieved weight lossKarthik Murugadoss, A J Venkatakrishnan, Christopher J Gregg, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2018
Codon usage of highly expressed genes affects proteome-wide translation efficiencyIdan Frumkin, Marc J Lajoie, Christopher J Gregg, et al.
Plos One|September 8, 2012
Improving lambda red genome engineering in Escherichia coli via rational removal of endogenous nucleasesJoshua A Mosberg, Christopher J Gregg, Marc J Lajoie, et al.
Nucleic Acids Research|January 24, 2014
Rational optimization of tolC as a powerful dual selectable marker for genome engineeringChristopher J Gregg, Marc J Lajoie, Michael G Napolitano, et al.
Blood|October 16, 2009
Evidence for a novel human-specific xeno-auto-antibody response against vascular endotheliumTho Pham, Christopher J Gregg, Felix Karp, et al.
Evolutionary Applications|January 9, 2015
Heart disease is common in humans and chimpanzees, but is caused by different pathological processesNissi Varki, Dan Anderson, James G Herndon, et al.
Nature|January 22, 2015
Biocontainment of genetically modified organisms by synthetic protein designDaniel J Mandell, Marc J Lajoie, Michael T Mee, et al.
The Journal of Experimental Medicine|July 14, 2010
Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acidRachel E Taylor, Christopher J Gregg, Vered Padler-Karavani, et al.
Anesthesia and Analgesia|August 14, 2010
β2-adrenergic receptor-coupled phosphoinositide 3-kinase constrains cAMP-dependent increases in cardiac inotropy through phosphodiesterase 4 activationChristopher J Gregg, Jochen Steppan, Daniel R Gonzalez, et al.
Pageof 2